Emergent BioSolutions Inc. (NYSE:EBS) announced today that the U.S. Food and Drug Administration (FDA) is allowing Emergent’s Bayview manufacturing facility to resume production of Johnson & Johnson’s (J&J) Covid-19 vaccine bulk drug substance. This resumption of manufacturing follows extensive reviews by FDA, weeks of diligent work, and close coordination with J&J and FDA to execute on Emergent’s quality enhancement plan.
The Storied 25 Year History Behind the Baltimore Biotech Manufacturing Facility Producing COVID-19 Vaccines
Emergent Biosolutions’ vaccine manufacturing plant in Baltimore has been the subject of many headlines this past year for its’ role in producing several COVID-19 Vaccines. However, the history of this facility goes back more than two decades.
CoapTech, Inc, a medical device company focused on delivering transformative solutions for minimally-invasive surgery, announced today it has received CE Mark certification, as well as an approved CPT Procedure Code for its PUMA-G System, the world’s first and only ultrasound gastrostomy system that allows physicians to place gastrostomy tubes at the point of care, using solely ultrasound imaging.
Developers of Baltimore’s Port Covington project are focusing on life sciences development, including a forthcoming project from Alexandria Real Estate.
As the first buildings at Port Covington begin to rise, the project’s developers have a vision for the mini-city sprouting on a South Baltimore peninsula as the nation’s next big biotech hub.
Early Charm, a venture studio that converts science to business, today announced the hiring of Dan Keeley to lead Lankenau Ventures, a new joint venture with Early Charm that aims to accelerate development and commercialization of medical inventions conceived by frontline healthcare workers.
Betamore and Frederick Innovative Technology Center, Inc. (FITCI) are collaborating on a new, more impactful, hybrid conference event, Founder City. Founder City brings together into one event some of the [….]
CARB-X is Funding Baltimore’s Novel Microdevices to Develop a Rapid and Portable Diagnostic for STDs Including Antibiotic-Resistant Infections
CARB-X is funding Novel Microdevices to develop a rapid and portable diagnostic for sexually transmitted diseases including antibiotic-resistant infections New portable battery-powered diagnostic is designed to be easy-to-use in any setting around [….]
Baltimore’s BondTrue Awarded Competitive Grant from the National Science Foundation Small Business Innovation Research Program Provides Seed Funding for R&D BALTIMORE, Md., March 30, 2021 – BondTrue, LLC (BondTrue) has been awarded [….]
The Association for Women in Science (AWIS) chapters of Baltimore, Bethesda, and Washington DC are excited to host our first event of the year together for our “Networking Social with [….]